Systemic lupus erithematosus: Benlysta wins backing from NICE
After previously rejecting the drug in 2011, NICE ( National Institute for Health and Care Excellence ) has approved lupus drug Benlysta ( Belimumab ) for limited use under a managed access scheme.
...
read article